Works matching IS 0195668X AND DT 2021
Results: 944
Sodium–glucose co-transporter inhibitors, iron therapy, and checkpoint inhibitors: new clinical and translational pieces of the heart failure puzzle.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4871, doi. 10.1093/eurheartj/ehab857
- By:
- Publication type:
- Article
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4885, doi. 10.1093/eurheartj/ehab733
- By:
- Publication type:
- Article
Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4930, doi. 10.1093/eurheartj/ehab722
- By:
- Publication type:
- Article
Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4978, doi. 10.1093/eurheartj/ehab708
- By:
- Publication type:
- Article
Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4887, doi. 10.1093/eurheartj/ehab704
- By:
- Publication type:
- Article
Improving survival after heart transplantation despite increasing complexity.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4944, doi. 10.1093/eurheartj/ehab517
- By:
- Publication type:
- Article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
- By:
- Publication type:
- Article
Effects of canagliflozin on human myocardial redox signalling: clinical implications.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4947, doi. 10.1093/eurheartj/ehab420
- By:
- Publication type:
- Article
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
SGLT2 inhibitors: the story continues to unfold.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4902, doi. 10.1093/eurheartj/ehab561
- By:
- Publication type:
- Article
Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4961, doi. 10.1093/eurheartj/ehab519
- By:
- Publication type:
- Article
Intravenous iron supplementation: novel anti-remodelling therapy for patients with heart failure?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4915, doi. 10.1093/eurheartj/ehab624
- By:
- Publication type:
- Article
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4964, doi. 10.1093/eurheartj/ehab618
- By:
- Publication type:
- Article
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4918, doi. 10.1093/eurheartj/ehab568
- By:
- Publication type:
- Article
Stanford experience of heart transplantation over five decades.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4934, doi. 10.1093/eurheartj/ehab416
- By:
- Publication type:
- Article
effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4905, doi. 10.1093/eurheartj/ehab411
- By:
- Publication type:
- Article
Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4982, doi. 10.1093/eurheartj/ehab403
- By:
- Publication type:
- Article
Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4981, doi. 10.1093/eurheartj/ehab401
- By:
- Publication type:
- Article
Leveraging non-coding RNAs to fight cardiovascular disease: the EU-CardioRNA network.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4881, doi. 10.1093/eurheartj/ehab326
- By:
- Publication type:
- Article
Appointment as Board Reviewer: Ik-Kyung Jang, MD, PhD.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4884, doi. 10.1093/eurheartj/ehab322
- By:
- Publication type:
- Article
Making connections to overcome arrhythmias.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4878, doi. 10.1093/eurheartj/ehab311
- By:
- Publication type:
- Article
How an 'accidental doctor' became a renowned cardiologist.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4876, doi. 10.1093/eurheartj/ehab305
- By:
- Publication type:
- Article
Para-aortic channel in congenital heart disease: computed tomography and transoesophageal echography depiction of an undescribed type of interatrial communication.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Spontaneous intramyocardial haemorrhage in a patient with wild-type transthyretin cardiac amyloidosis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
update on triglyceride-rich lipoproteins and their remnants in atherosclerotic cardiovascular disease.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4777, doi. 10.1093/eurheartj/ehab844
- By:
- Publication type:
- Article
Mineral oil and icosapent ethyl may jointly explain the between arm difference of cardiovascular risk in REDUCE-IT.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4867, doi. 10.1093/eurheartj/ehab764
- By:
- Publication type:
- Article
reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4865, doi. 10.1093/eurheartj/ehab760
- By:
- Publication type:
- Article
PCSK9 inhibition for acute arterial events: more than LDL lowering.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney disease.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4789, doi. 10.1093/eurheartj/ehab725
- By:
- Publication type:
- Article
Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4847, doi. 10.1093/eurheartj/ehab660
- By:
- Publication type:
- Article
Investigating contrasting results in REDUCE-IT and STRENGTH: partial answers but questions remain.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
changing nature of atherosclerosis: what we thought we knew, what we think we know, and what we have to learn.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4781, doi. 10.1093/eurheartj/ehab438
- By:
- Publication type:
- Article
Waiting for the light at the end of the COVID-19 tunnel: best and worst moments 1 year into the pandemic.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4783, doi. 10.1093/eurheartj/ehab367
- By:
- Publication type:
- Article
Two birds, one stone: NFATc3 controls dual actions of miR-204 in foam cell formation.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4862, doi. 10.1093/eurheartj/ehab640
- By:
- Publication type:
- Article
possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4807, doi. 10.1093/eurheartj/ehab555
- By:
- Publication type:
- Article
Lipoprotein remnants: to be or not to be.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4787, doi. 10.1093/eurheartj/ehab358
- By:
- Publication type:
- Article
Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4821, doi. 10.1093/eurheartj/ehab604
- By:
- Publication type:
- Article
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4791, doi. 10.1093/eurheartj/ehab551
- By:
- Publication type:
- Article
Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
- Published in:
- European Heart Journal, 2021, v. 42, n. 47, p. 4833, doi. 10.1093/eurheartj/ehab293
- By:
- Publication type:
- Article
'normotensive' adult with dysplastic double aortic arch.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
In vivo paradoxical embolism during monitorization of extracorporeal membrane oxygenation implantation.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
- Published in:
- European Heart Journal, 2021, v. 42, n. 46, p. 4703, doi. 10.1093/eurheartj/ehab830
- By:
- Publication type:
- Article
Another STEP towards tighter control of blood pressure in the elderly.
- Published in:
- European Heart Journal, 2021, v. 42, n. 46, p. 4715, doi. 10.1093/eurheartj/ehab728
- By:
- Publication type:
- Article
Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Virtual delivery of cardiopulmonary resuscitation training for the public: how to make it work.
- Published in:
- European Heart Journal, 2021, v. 42, n. 46, p. 4710, doi. 10.1093/eurheartj/ehab652
- By:
- Publication type:
- Article
Application of artificial intelligence to the electrocardiogram.
- Published in:
- European Heart Journal, 2021, v. 42, n. 46, p. 4717, doi. 10.1093/eurheartj/ehab649
- By:
- Publication type:
- Article
AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 46, p. 4731, doi. 10.1093/eurheartj/ehab569
- By:
- Publication type:
- Article